Cube Biotech Email Format

Biotechnology ResearchBavaria, Germany51-200 Employees

Cube Biotech is a membrane protein–focused contract research organization in the biotechnology research industry, based in Monheim, Bavaria, Germany, with 51-200 employees. The company offers non-GMP services across protein preparation, biophysical target characterization, and structure determination by cryo-EM or assay development. Its portfolio includes a broad synthetic copolymer library intended to provide a more native view of membrane proteins than traditional detergents. Cube Biotech provides flexible engagement models, including FTE-based, fee-for-service, and milestone-based arrangements, and pursues long-term collaborations with industrial and academic partners. In 2025 the company announced leadership changes, appointing Michael Bencak as CEO and Dr. Joachim Kreuzburg to its Board of Directors, and reported strategic activities such as integration with Isogenica Limited and the acquisition of IBA Lifesciences, as well as collaborations related to GPCR-targeted therapeutics.

Sign up for free to view info

Company overview Employee directory